Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125731271 | 12573127 | 1 | I | 2009 | 20160711 | 20160720 | 20160720 | EXP | US-ASTRAZENECA-2016SE77878 | ASTRAZENECA | 0.00 | A | M | Y | 0.00000 | 20160720 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125731271 | 12573127 | 1 | PS | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | 20838 | TABLET | ||||||||||
| 125731271 | 12573127 | 2 | SS | BLOPRESS | CANDESARTAN CILEXETIL | 1 | Oral | 4 MG TWICE A DAY (4 MG IN THE MORNING AND 4 MG IN THE EVENING) | 20838 | TABLET | |||||||||
| 125731271 | 12573127 | 3 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | SIGNIFICANTLY UNDER 3 GRAM | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125731271 | 12573127 | 1 | Hypertension |
| 125731271 | 12573127 | 2 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125731271 | 12573127 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125731271 | 12573127 | Aneurysm |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125731271 | 12573127 | 1 | 2009 | 0 |